Presented at Molecular Med Tri-Con
MARCH 3, 2020
Navigating the path to developing Companion Diagnostics in Immuno-Oncology can be challenging. This presentation will discuss the approach to developing high quality prototype companion Dx IHC assays and their utility in patient selection and potential pivot to a Companion Dx approach.
Have a question related to this presentation? Submit this form and we will get you answers.
Join Discovery Life Sciences at I/O Summit Europe 2024 April 23-25, 2024 | Hilton London Canary Wharf, London, England
Join Discovery Life Sciences in Booth #11 at CB & CDx London 2024 April 24-25, 2024 | Millennium Gloucester Hotel London Kensington, London, England
Join Discovery Life Sciences at Cyto Conference 2024 May 4-8, 2024 | Edinburgh International Convention Center, Edinburgh, Scotland
Copyright © 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing
